ABEONA THERAPEUTICS INC. Income Statement
ABEO|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
ABEONA THERAPEUTICS INC. reported $6M in revenue and $71M in net income for FY2025. Revenue has grown at a 19.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8M | $3.5M | $1.4M | $3.0M | $10.0M | $10.0M | $837.0K | $3.0M | $837.0K | $1.0M | $925.0K | $925.0K | $4.4M | $1.8M | $481.0K |
| Cost of Revenue | $1.5M | - | - | - | - | - | - | - | - | - | - | $0 | $267.0K | $148.0K | $140.0K |
| SG&A Expense | $65.0M | $19.0M | $17.3M | $21.6M | $23.8M | $20.7M | $10.9M | $20.1M | $10.9M | $14.3M | $3.7M | $3.7M | $6.0M | $5.8M | $4.5M |
| R&D Expense | $26.8M | $31.1M | $29.0M | $38.7M | $30.1M | $48.6M | $17.0M | $38.7M | $17.0M | $4.7M | $333.0K | $333.0K | $2.0M | $3.6M | $3.3M |
| Operating Income | -$89.4M | -$47.1M | -$50.9M | -$89.8M | -$81.4M | -$77.1M | -$27.8M | -$58.2M | -$27.8M | -$18.5M | -$3.1M | -$3.1M | -$4.3M | -$7.9M | -$7.8M |
| Interest Expense | $3.7M | $418.0K | $736.0K | $3.7M | $4.1M | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $100.0K | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $17.0K | $0 |
| Net Income | $71.2M | -$54.2M | -$39.7M | -$84.9M | -$84.2M | -$76.3M | -$27.3M | -$56.7M | -$27.3M | -$14.5M | -$26.8M | -$26.8M | -$10.5M | -$2.5M | -$7.5M |
| EPS (Basic) | -$1.55 | -$2.53 | -$5.53 | -$21.57 | - | - | - | - | - | - | - | $3.07 | -$0.52 | - | - |
| EPS (Diluted) | -$1.55 | -$2.53 | -$5.53 | - | -$0.91 | -$1.51 | -$0.66 | -$0.64 | -$0.64 | -$0.53 | -$15.26 | $3.04 | -$0.52 | -$0.22 | -$0.60 |
| Shares Outstanding | 45.6M | 26.5M | 17.7M | 5.9M | 96.1M | 83.6M | 47.9M | 46.9M | 40.3M | 27.6M | 1.9M | 509.5K | 24.2M | 20.0M | - |
| Operating Margin | -1536.9% | -1346.7% | -3600.8% | -2994.5% | -814.2% | -770.9% | -3325.7% | -1940.2% | -3325.7% | -1783.3% | -338.5% | -338.5% | -98.0% | -428.3% | -1612.7% |
| Profit Margin | 1223.1% | -1548.2% | -2807.4% | -2831.2% | -842.3% | -762.8% | -3263.9% | -1890.3% | -3263.9% | -1396.7% | -2894.9% | -2894.9% | -239.2% | -137.7% | -1566.9% |